Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 151313
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis.

Scope of the Report:

This report focuses on the Diagnostic Radiopharmaceuticals & Contrast Media in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and diagnostics and high prevalence of cancers and cardiac diseases.

The worldwide market for Diagnostic Radiopharmaceuticals & Contrast Media is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amag Pharmaceuticals

Bayer Healthcare

Bracco Imaging

Daiichi Sankyo

GE Healthcare

Guerbet

Lantheus

Mallinckrodt

Medtronic

Nordion

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Radiopharmaceuticals

Contrast Media

Market Segment by Applications, can be divided into

Diagnostic

Therapeutic

Ionizing Radiation based Radioimaging

Non-Ionizing Radiation based Radioimaging

There are 15 Chapters to deeply display the global Diagnostic Radiopharmaceuticals & Contrast Media market.

Chapter 1, to describe Diagnostic Radiopharmaceuticals & Contrast Media Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, with sales, revenue, and price of Diagnostic Radiopharmaceuticals & Contrast Media, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Diagnostic Radiopharmaceuticals & Contrast Media, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Diagnostic Radiopharmaceuticals & Contrast Media market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Diagnostic Radiopharmaceuticals & Contrast Media sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Diagnostic Radiopharmaceuticals & Contrast Media Introduction

1.2 Market Analysis by Type

1.2.1 Radiopharmaceuticals

1.2.2 Contrast Media

1.3 Market Analysis by Applications

1.3.1 Diagnostic

1.3.2 Therapeutic

1.3.3 Ionizing Radiation based Radioimaging

1.3.4 Non-Ionizing Radiation based Radioimaging

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amag Pharmaceuticals

2.1.1 Business Overview

2.1.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bayer Healthcare

2.2.1 Business Overview

2.2.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bracco Imaging

2.3.1 Business Overview

2.3.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Daiichi Sankyo

2.4.1 Business Overview

2.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 GE Healthcare

2.5.1 Business Overview

2.5.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Guerbet

2.6.1 Business Overview

2.6.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Lantheus

2.7.1 Business Overview

2.7.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Mallinckrodt

2.8.1 Business Overview

2.8.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Medtronic

2.9.1 Business Overview

2.9.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Nordion

2.10.1 Business Overview

2.10.2 Diagnostic Radiopharmaceuticals & Contrast Media Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share in 2017

3.3.2 Top 6 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis by Regions

4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Regions

4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Regions (2013-2018)

4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Regions (2013-2018)

4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

5 North America Diagnostic Radiopharmaceuticals & Contrast Media by Countries

5.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Countries

5.1.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Countries (2013-2018)

5.1.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Countries (2013-2018)

5.2 United States Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

5.3 Canada Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

5.4 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

6 Europe Diagnostic Radiopharmaceuticals & Contrast Media by Countries

6.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Countries

6.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Countries (2013-2018)

6.2 Germany Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

6.3 UK Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

6.4 France Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

6.5 Russia Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

6.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

7 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media by Countries

7.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Countries (2013-2018)

7.2 China Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

7.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

7.4 Korea Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

7.5 India Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

8 South America Diagnostic Radiopharmaceuticals & Contrast Media by Countries

8.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Countries

8.1.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Countries (2013-2018)

8.1.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

8.3 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

8.4 Colombia Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

9 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media by Countries

9.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

9.3 UAE Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

9.4 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

9.5 Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

9.6 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales and Growth Rate (2013-2018)

10 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Segment by Type

10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales and Market Share by Type (2013-2018)

10.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2013-2018)

10.2 Radiopharmaceuticals Sales Growth and Price

10.2.1 Global Radiopharmaceuticals Sales Growth (2013-2018)

10.2.2 Global Radiopharmaceuticals Price (2013-2018)

10.3 Contrast Media Sales Growth and Price

10.3.1 Global Contrast Media Sales Growth (2013-2018)

10.3.2 Global Contrast Media Price (2013-2018)

11 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Segment by Application

11.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2013-2018)

11.2 Diagnostic Sales Growth (2013-2018)

11.3 Therapeutic Sales Growth (2013-2018)

11.4 Ionizing Radiation based Radioimaging Sales Growth (2013-2018)

11.5 Non-Ionizing Radiation based Radioimaging Sales Growth (2013-2018)

12 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Growth Rate (2018-2023)

12.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Regions (2018-2023)

12.2.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.2.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.2.3 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.2.4 South America Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.2.5 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2018-2023)

12.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Type (2018-2023)

12.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Type (2018-2023)

12.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Type (2018-2023)

12.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Application (2018-2023)

12.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Application (2018-2023)

12.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Diagnostic Radiopharmaceuticals & Contrast Media Picture

Table Product Specifications of Diagnostic Radiopharmaceuticals & Contrast Media

Figure Global Sales Market

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery